Lupin Enters Canadian Biosimilars Market With Etanercept

Rymti Rival To Amgen’s Enbrel Is Launched With Partner Sandoz

 
• By Dave Wallace
  
Canada flag five vials syringes
Lupin has launched its first Canadian biosimilar • Source: Shutterstock

More from Biosimilars

More from Products